Oncology experience
- AstraZeneca Oncology: multi-product franchise for estrogen receptor-positive breast cancers, including prevention, neo-adjuvant, 1st and 2nd line metastatic cancers
- Bayer Oncology: oral kinase inhibitor for renal cell carcinoma, hepatocellular carcinoma, and thyroid carcinoma
- BMS Oncology: checkpoint inhibitor for PD-L1 tumors including NSCLC, pipeline tumors, as wells as biomarker and diagnostic partnerships
- Celgene Oncology: nanoparticle paclitaxel for metastatic breast cancer, metastatic pancreatic cancer, and non-small cell lung cancer
- GSK Oncology: US and global pipeline portfolio including anti-emetics for chemotherapy induced nausea and vomiting
- Janssen Pain Franchise: fentanyl patch for metastatic cancer pain relief and chronic pain control
- J&J Oncology Supportive Care: erythropoietin for chronic renal failure and chemotherapy-induced anemia
- Novartis Oncology: small-molecule tyrosine kinase inhibitor for chronic myeloid leukemia plus companion diagnostics in CML
- Roche Genentech Oncology: monoclonal antibody for metastatic HER2-positive breast cancer
Additional category experience
- AbbVie: the #1 biologic, a TNF-inhibitor for gastrointestinal indications including Crohn’s and ulcerative colitis
- Allergan and P&G: oral 5-ASA for moderate ulcerative colitis
- Corcept: cortisol receptor blocker for Cushing’s syndrome in type 2 diabetes patients
- DUSA Dermatology: aminolevulinic acid for actinic keratosis
- Galderma Dermatology: prescription franchise for acne, rosacea, psoriasis, melasma and aesthetic products
- Pfizer Vaccines: global agency brand leader for the world’s #1 pneumococcal pneumonia conjugate vaccine